Latest filing published 16 Oct 2026 for PharmaCielo Ltd., €5,056.
Douglas Bache is a declared insider of PharmaCielo Ltd., with filings sourced from SEDI. Between 1 September 2026 and 16 October 2026, the trades on record add up to 8 filings.
The open-market side counts 7 purchases for €37k alongside 1 sale for €2,392. Purchases outweigh sales by €35k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €3,755. Relative to company size, the median is 0.045% of market cap (7 purchases with a known value). No cluster: in 7 purchases, no other insider of the company bought within 30 days.
On 16 October 2026 came the latest disclosure, an open-market purchase for €5,056 in PharmaCielo Ltd. Publication is fast: at least half of the trades appear on SEDI on the same day. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations